Asia-Pacific Americas Africa Europe Middle East

NATCO PHARMA LIMITED

Company Profile:

NATCO PHARMA LIMITED

Company Introduction:

NATCO PHARMA LIMITED is an Indian pharmaceutical company. It is a manufacturer.

NATCO PHARMA LIMITED is a vertically integrated pharmaceutical company based in Hyderabad, India. The company is primarily engaged in the research, development, manufacturing, and marketing of finished dosage formulations and active pharmaceutical ingredients (APIs). Natco has a strong presence in various therapeutic areas, including oncology, cardiology, gastroenterology, and diabetology. It is known for its focus on complex generics and innovative products, often being one of the first companies to launch generic versions of patented drugs in India. The company operates multiple manufacturing facilities that are approved by major regulatory bodies globally, including the US FDA.

Enterprise Products

NATCO PHARMA LIMITED manufactures and sells a wide range of pharmaceutical products, primarily focusing on complex generics and niche therapeutic areas. Their product portfolio includes:

Oncology Products:

Lenalidomide

Imatinib Mesylate

Erlotinib

Dasatinib

Bortezomib

Pomalidomide

Sorafenib

Capecitabine

Everolimus

Palbociclib

Acalabrutinib

Ruxolitinib

Doxorubicin Liposomal

Gemcitabine

Paclitaxel

Docetaxel

Cisplatin

Carboplatin

Oxaliplatin

Methotrexate

Hepatology Products (especially for Hepatitis C and B):

Sofosbuvir

Ledipasvir and Sofosbuvir

Daclatasvir

Velpatasvir and Sofosbuvir

Ribavirin

Tenofovir Disoproxil Fumarate

Entecavir

Gastroenterology Products:

Proton Pump Inhibitors (e.g., Omeprazole, Pantoprazole)

Anti-emetics

Anti-ulcerants

Cardiology Products:

Statins (e.g., Rosuvastatin, Atorvastatin)

Anti-hypertensives (e.g., Telmisartan, Amlodipine)

Anti-platelet agents

Diabetology Products:

Anti-diabetic medications (e.g., Metformin, Gliclazide)

Nephrology Products:

Immunosuppressants (e.g., Mycophenolate Mofetil)

Erythropoiesis-stimulating agents

Critical Care Products:

Various injectables and essential medicines for intensive care settings

Central Nervous System (CNS) Products:

Antidepressants

Antipsychotics

Antiepileptics

Virology Products (beyond Hepatitis):

Antiretrovirals (e.g., Dolutegravir, Emtricitabine, Tenofovir combinations)

Active Pharmaceutical Ingredients (APIs):

They also manufacture and supply Active Pharmaceutical Ingredients for many of their finished dosage forms and to other pharmaceutical companies globally.

Business Registration Information:

Manager:

Mr. Rajeev Nannapaneni (Vice Chairman & CEO)

Phone:

+91 40 23547575, +91 40 23545638

E-mail:

investor@natcopharma.co.in

Official Website:
Address:

NATCO House, Road No. 2, Banjara Hills, Hyderabad - 500 034, Telangana, India.

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.